Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1998-5-21
|
pubmed:abstractText |
Previous studies from our laboratory show that ethanol consumption impairs antigen-specific, cell-mediated, but not, humoral immune responses of C57BL/6, BALB/c, and DO11.10 T-cell receptor transgenic mice. This ethanol-associated deficit is associated with decreased interleukin (IL)-12 and interferon-gamma (IFN-gamma) production, but not IL-2 or antigen-specific T-cell proliferation by explanted leukocytes from ethanol-consuming mice. IL-12 expression by macrophage/monocytes is viewed as a requirement for the production of IFN-gamma by Th1 lymphocytes that mediate cellular immunity. In this study, we restored antigen-specific, cell-mediated immunity, delayed hypersensitivity, to ethanol-consuming C57BL/6 or BALB/c mice with a single 100 ng of intravenous injection of recombinant IL-12 at the time of immunization. The addition of exogenous recombinant IL-12 to co-cultures of antigen-presenting cells derived from ethanol-consuming mice and purified T cells derived from ethanol-nonconsuming DO11.10 repairs the ability of Th1 cells to make IFN-gamma in response to antigen. Administration of recombinant IL-12 opens a potential for restoring cell-mediated immune function to ethanol-consuming individuals.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0145-6008
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
22
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
245-51
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:9514314-Alcoholism,
pubmed-meshheading:9514314-Animals,
pubmed-meshheading:9514314-Female,
pubmed-meshheading:9514314-Immune Tolerance,
pubmed-meshheading:9514314-Immunity, Cellular,
pubmed-meshheading:9514314-Injections, Intravenous,
pubmed-meshheading:9514314-Interleukin-12,
pubmed-meshheading:9514314-Lymphocyte Activation,
pubmed-meshheading:9514314-Mice,
pubmed-meshheading:9514314-Mice, Inbred BALB C,
pubmed-meshheading:9514314-Mice, Inbred C57BL,
pubmed-meshheading:9514314-Recombinant Proteins
|
pubmed:year |
1998
|
pubmed:articleTitle |
Interleukin-12 therapy restores cell-mediated immunity in ethanol-consuming mice.
|
pubmed:affiliation |
Department of Microbiology-Immunology, Northwestern University Medical School, Chicago, Illinois 60611-3072, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|